Navigation Links
Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
Date:5/14/2009

search and development.

For more information, please visit http://us.boehringer-ingelheim.com

References

  1. Li D et al. "BIBW2992, an irreversible EGFR/HER2 inhibitor highlyeffective in preclinical lung cancer models." Oncogene 2008;27:4702-4711
  2. Shih J-Y et al. "A Phase II study of BIBW 2992, a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor (TKI), in patients with adenocarcinoma of the lung and activating EGFR mutations after failure of 1 line of chemotherapy (LUX-Lung 2)." Poster Discussion Presentation. 1 June 2009, Session Time: 8:00AM - 12:00PM. #8013
  3. "Ask the Expert Online Q&A: Are the number of cancer cases increasing or decreasing in the world?" 1 April 2008. World Health Organization. 5 May 2009. http://www.who.int/features/qa/15/en/print.html.
  4. Boehringer Ingelheim Pharmaceuticals. "BIBW 2992 and BSC Versus Placebo and BSC in Non-Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)" 23 April 2009. ClinicalTrials.gov. 5 May 2009. http://clinicaltrials.gov/ct2/show/NCT00656136?term=BIBW+2992+and+Phase+III&rank=1.
  5. Yang C-H et al. "Phase IIb/III double-blind randomized trial of BIBW 2992, an irreversible, dual inhibitor of EGFR and HER2 plus best supportive care (BSC) versus placebo plus BSC in patients with NSCLC failing 1-2 lines of chemotherap
    '/>"/>

SOURCE Boehringer Ingelheim
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Dec. 17 CANTEL MEDICAL CORP. ... Board of Directors intends to pay, for the first ... share, or $0.10 per share annually, on the Company,s ... of $0.05 per share of outstanding common stock, to ... record at the close of business on January 15, ...
(Date:12/17/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, Negative Pressure ... Market Forecasts to 2016 ,, ... Pressure Wound Therapy (NPWT) Pipeline Technology ... Summary ,, "Negative Pressure ...
(Date:12/17/2009)... CITY, Fla., Dec, 17 Connectyx Technologies ... that it has formed a distribution partnership with ... distributor of Diabetic Supplies, Respiratory Supplies and Medications ... VED Erectile Dysfunction System. ,, Terms of the ... Schuman stated that, "This partnership adds to our ...
Breaking Medicine Technology:Cantel Medical Authorizes Semiannual Dividend 2Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 2Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 3Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 4Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 5Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 6Connectyx Announces Distribution Partnership with United States Medical Supply 2Connectyx Announces Distribution Partnership with United States Medical Supply 3Boston Scientific to Participate in BMO Capital Markets Health Care Conference 53533 1Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 1Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 2Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 3Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 4Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 5Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 6Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 7Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 53529 8Leading Boston Dermatologist Performs Live Artefill Patient Demonstration at American Academy of Dermatology Summer Meeting 53525 1Leading Boston Dermatologist Performs Live Artefill Patient Demonstration at American Academy of Dermatology Summer Meeting 53525 2
... rights of its exclusive licensee in Japan after Itochu ... Japan for cosmeceutical and dietary supplement products using patented ... demand fueled by results of new research showing that ... collagen III in the epidermis layer of the skin. ...
... II Testing Certification with Edifecs CORE Testing Service - ... X12 Version 5010BELLEVUE, Wash., April 5 ... partners CAQH and Harvard Pilgrim Health Care, examine the ... Certification testing including elements of the newly mandated 5010 ...
Other Medicine Technology:Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan 2Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan 3Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5
(Date:12/17/2009)... Today, SEIU ULTCW (United Long Term Care Workers, ... (IHSS) providers have overwhelmingly voted in favor of ... multiple layers of protection to the current homecare ... granting additional contract improvements. ,, "As several ... homecare provider wages to as low as minimum ...
(Date:12/17/2009)... Racial and ethnic disparities in cancer survival ... early and treated successfully, including breast and prostate ... Columbia University,s Mailman School of Public Health and ... University Medical Center/NewYork-Presbyterian Hospital. Disparities are small ... early detection and treatment options, such as pancreatic ...
(Date:12/17/2009)... phone use in era of sexually explicit messaging, experts ... Teens and preteens spend hours sending text messages from ... those messages -- sexually explicit material, giving the messaging ... parents, University of Michigan researchers report. , In fact, ... parents are worried about the time their children spend ...
(Date:12/17/2009)... doses delivered during computed tomography examinations underscore the important ... dose and protecting patients, according to the American Society ... ... Albuquerque, NM (Vocus) December 16, 2009 -- ... tomography examinations underscore the important role that competent, educated ...
(Date:12/17/2009)... Dec. 17 Motionsoft, Inc. announced today ... Card Industry (PCI) Data Security Standards (DSS) certification, ... software vendors in the health and wellness space ... PCI Standard is the result of a collaborative ... companies (Visa International, MasterCard Worldwide, American Express, Discover ...
Breaking Medicine News(10 mins):Health News:New Alameda County IHSS Contract Sends Clear Message to Elected Leaders That Homecare Program Must Remain a California Priority 2Health News:Cancer survival disparities for most minority populations increase as cancers become more treatable 2Health News:'Sexting' by Kids Begets Fretting by Parents 2Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 2Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 3Health News:ASRT Supports Efforts to Minimize CT Radiation Dose 4Health News:Motionsoft Completes PCI Compliance Certification 2
... of sources in the environment and from industry and ... via the diet and drinking water. In chronic exposure, ... kidneys and the liver. The liver acts as a ... gastrointestinal tract and liver cells can be exposed to ...
... struggling at home almost every day , WEDNESDAY, Jan. 16 ... can occur daily and is much more severe than previously ... who kept diaries to record daily pain and whether they ... pain. , "The major finding of our study was that ...
... Every year, 759,000 children with asthma may be at risk ... insurance. About 30 percent of those families earn more than ... the threshold for the state childrens health insurance program in ... are without insurance at some point during the year, said ...
... to Signal Commitment to,Health of Babies, WHITE PLAINS, N.Y., ... brought in $117 million,nationwide last year, has been renamed March ... the March of Dimes is all about -- the health ... our mission stays the same --,working towards the day when ...
... On January 14, Dr. Judah,Folkman, founder of the field ... to Vancouver for one of the thousands of lectures,that ... and scientific,pioneer, Dr. Folkman was founder and director of ... professor of Pediatric Surgery,and Cell Biology at Harvard Medical ...
... had 47% higher risk of cardiovascular trouble , , TUESDAY, ... by millions of postmenopausal women to reduce their risk ... heart attack and other cardiovascular problems. , The findings ... , "There are data from other recent studies showing ...
Other Medicine News:Health News:Sickle Cell Patients in More Pain Than Thought 2Health News:759,000 children with asthma endure gaps in insurance every year 2Health News:WalkAmerica Is Now March for Babies 2Health News:Children's Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis 2Health News:Children's Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis 3Health News:Children's Hospital Boston Mourns the Death of Dr. Judah Folkman, World Renowned Researcher and Founder of the Field of Angiogenesis 4Health News:Calcium Supplements Could Raise Heart Risks in Postmenopausal Women 2Health News:Calcium Supplements Could Raise Heart Risks in Postmenopausal Women 3Health News:Calcium Supplements Could Raise Heart Risks in Postmenopausal Women 4
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 6.0mm....
Infusion Cannula, 4.0mm....
Medicine Products: